This work proposes a novel, multidimensional framework for understanding the role of psychological morbidity (anxiety and depressive symptoms), dopaminergic signaling (DRD1 and DRD4 expression), and inflammation (NLR) in the relationship between maladaptive psychological responses (PTSS and rumination) and QoL. The gene discussed is DRD1; the disease is Anxiety.